Dres, Sitte N.
HRN: 03-16-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2022
CEFUROXIME 1.5GM (VIAL)
09/07/2022
09/13/2022
IV
1.5g
Q8h
UTI; Covid Pneumonia Mild; CAP LR
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes